The science behind Medix Biochemica’s innovations
Our R&D Capabilities
Medix Biochemica’s scientific professionals have decades of experience on the development of essential raw materials for diagnostic applications. With 1 of 4 employees dedicated to design and development of new products, we are able to keep up with the cutting-edge of all aspects of the IVD industry — from native and recombinant antibodies and antigens to molecular diagnostic reagents. Our customer-centric approach makes us the ideal partner to meet your needs. Our R&D and analytical teams also utilize their expertise to develop assay methods, purification schemes, and tailor or scale up processes to deliver the right product and solutions for our clients’ final application. Please get in touch with us today to discuss your bespoke needs.
Monoclonal antibody development
Medix Biochemica has been a pioneer in monoclonal antibody development since the late 1970’s. We have world-leading expertise in developing novel antibodies for all types of molecules relevant in IVD, both with mouse hybridoma and phage display technologies. Our R&D professionals also have thorough knowledge and experience on the adaptation of antibody-producing cell lines to industrial scale animal-free manufacturing processes.
State-of-the-art recombinant technologies are also used in our product development department to develop engineered antibodies. We rescue antibodies from hybridomas to recombinant form and switch the domains between different species when needed. We analyze antibody structures computationally and engineer them for enhanced performance, to ensure our customers will have the best options available for their IVD tests.
Latest News
View our most recent articles and news.